Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a
sand fly. It is endemic in Asia, Africa, the Americas, and the Mediterranean region …

Cutaneous leishmaniasis is endemic in the tropics and neotropics. It is often referred to as a
group of diseases because of the varied spectrum of clinical manifestations, which range …

Leishmaniasis is a global term for cutaneous and visceral anthroponotic and zoonotic
diseases caused by the vector-borne parasites of the genus Leishmania. These diseases …

Leishmaniases remain a major public health problem today despite the vast amount of
research conducted on Leishmania pathogens. The biological model is genetically and …

Mathematical models are powerful tools to study various real-world problems from different
perspectives. This branch has been given much more popularity over the last several …

Leishmaniasis, usually caused by the genus Leishmania, has not received the attention it
deserves and in recent times has developed into a major health problem worldwide. 1, 2 …

Progress has been made in the control or elimination of tropical diseases, with a significant
reduction of incidence. However, there is a risk of re-emergence if the factors fueling …

The first steps in leishmaniasis are critical in determining the evolution of the disease. Major
advances have recently been done in understanding this crucial moment. Fundamental …

Human infection by the vector‐borne protozoan Leishmania is responsible for substantial
worldwide morbidity and mortality. The surface‐metalloprotease (leishmanolysin) of …

The major goal of this work was to design a new nanoparticle drug delivery system for
desoxycholate amphotericin B (D-AMB), based on controlled particle size, looking for the …